Jason Butler

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

Robert Zeiser, Nikolas von Bubnoff, Jason Butler et al. · New England Journal of Medicine · 2020 · 814 citations · Full text

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nathan Fowler, Michael Dickinson, Martin Dreyling et al. · Nature Medicine · 2021 · 492 citations · Full text

Lymphoid Neoplasia, Hematology, Immunology +6

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Glen Kennedy, Antiopi Varelias, Slavica Vučković et al. · The Lancet Oncology · 2014 · 211 citations

Inflammation, Phase 1/2, Cell Therapy +13

Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications

Siok‐Keen Tey, Glen Kennedy, Deborah Cromer et al. · PLoS ONE · 2013 · 92 citations · Full text

Cell Therapy, Immunodeficiencies, Immunology +18

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

Martin Dreyling, Nathan Fowler, Michael Dickinson et al. · Blood · 2024 · 81 citations · Full text

Immunodeficiencies, Immunology, Pathology +23